Federated Hermes, Inc. Omnicell, Inc Transaction History

Federated Hermes, Inc.

$52.5 Billion
Q3 2025

A detailed history of Federated Hermes, Inc. transactions in Omnicell, Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 525,439 shares of OMCL stock, worth $18.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

525,439

Previous 594,944 11.68%

Holding current value

$18.5 Million

Previous $17.5 Million 8.53%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$26.88 - $33.62 $1.87 Million - $2.34 Million	-69,505 Reduced 11.68%	525,439 $16 Million
Q2 2025 Aug 13, 2025	SELL	$24.63 - $35.46 $3.73 Million - $5.37 Million	-151,555 Reduced 20.3%	594,944 $17.5 Million
Q1 2025 May 08, 2025	SELL	$32.31 - $45.32 $1.33 Million - $1.87 Million	-41,248 Reduced 5.24%	746,499 $26.1 Million
Q4 2024 Feb 13, 2025	SELL	$39.5 - $53.05 $2.43 Million - $3.27 Million	-61,570 Reduced 7.25%	787,747 $35 Million
Q3 2024 Nov 13, 2024	SELL	$25.61 - $45.43 $3.63 Million - $6.44 Million	-141,834 Reduced 14.31%	849,317 $37 Million
Q2 2024 Aug 08, 2024	BUY	$26.22 - $32.65 $23.8 Million - $29.7 Million	909,480 Added 1113.59%	991,151 $26.8 Million
Q1 2024 May 14, 2024	BUY	$26.15 - $37.33 $99,631 - $142,227	3,810 Added 4.89%	81,671 $2.39 Million
Q4 2023 Jan 31, 2024	SELL	$29.24 - $45.81 $7.13 Million - $11.2 Million	-243,690 Reduced 75.79%	77,861 $2.93 Million
Q3 2023 Nov 13, 2023	BUY	$44.6 - $73.38 $359,788 - $591,956	8,067 Added 2.57%	321,551 $14.5 Million
Q2 2023 Aug 14, 2023	SELL	$57.88 - $75.94 $1.74 Million - $2.28 Million	-29,978 Reduced 8.73%	313,484 $23.1 Million
Q1 2023 May 08, 2023	SELL	$51.51 - $60.43 $20.1 Million - $23.6 Million	-391,103 Reduced 53.24%	343,462 $20.2 Million
Q4 2022 Feb 13, 2023	BUY	$46.24 - $90.03 $33.1 Million - $64.4 Million	714,897 Added 3634.82%	734,565 $37 Million
Q3 2022 Nov 14, 2022	BUY	$84.23 - $117.38 $1.65 Million - $2.3 Million	19,608 Added 32680.0%	19,668 $1.71 Million
Q2 2022 Aug 15, 2022	SELL	$105.64 - $129.11 $11,831 - $14,460	-112 Reduced 65.12%	60 $7,000
Q1 2022 May 13, 2022	SELL	$120.68 - $180.51 $10,137 - $15,162	-84 Reduced 32.81%	172 $22,000
Q4 2021 Feb 14, 2022	SELL	$153.26 - $183.62 $273,262 - $327,394	-1,783 Reduced 87.44%	256 $46,000
Q3 2021 Nov 15, 2021	SELL	$141.84 - $160.88 $2.42 Million - $2.74 Million	-17,045 Reduced 89.32%	2,039 $303,000
Q2 2021 Aug 16, 2021	SELL	$129.91 - $151.45 $7.02 Million - $8.19 Million	-54,046 Reduced 73.9%	19,084 $2.89 Million
Q1 2021 May 13, 2021	SELL	$117.78 - $143.9 $714,806 - $873,329	-6,069 Reduced 7.66%	73,130 $9.5 Million
Q4 2020 Feb 12, 2021	SELL	$73.85 - $120.02 $2.04 Million - $3.32 Million	-27,680 Reduced 25.9%	79,199 $9.51 Million
Q3 2020 Nov 12, 2020	BUY	$63.15 - $77.12 $5.86 Million - $7.15 Million	92,747 Added 656.29%	106,879 $7.98 Million
Q2 2020 Aug 13, 2020	BUY	$59.36 - $74.43 $813,291 - $1.02 Million	13,701 Added 3178.89%	14,132 $998,000
Q1 2020 May 13, 2020	SELL	$55.41 - $90.19 $657,384 - $1.07 Million	-11,864 Reduced 96.49%	431 $29,000
Q4 2019 Feb 14, 2020	SELL	$70.15 - $83.11 $599,782 - $710,590	-8,550 Reduced 41.02%	12,295 $1.01 Million
Q3 2019 Nov 14, 2019	SELL	$68.36 - $88.34 $4.09 Million - $5.29 Million	-59,830 Reduced 74.16%	20,845 $1.51 Million
Q2 2019 Aug 14, 2019	BUY	$71.38 - $92.21 $5.74 Million - $7.42 Million	80,467 Added 38686.06%	80,675 $6.94 Million
Q1 2019 May 10, 2019	BUY	$58.88 - $86.19 $12,247 - $17,927	208 New	208 $17,000
Q1 2018 May 09, 2018	SELL	$40.1 - $52.45 $18,004 - $23,550	-449 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$45.3 - $54.5 $543 - $654	-12 Reduced 2.6%	449 $0
Q3 2017 Nov 13, 2017	BUY	$48.1 - $52.15 $22,174 - $24,041	461	461 $24,000

Others Institutions Holding OMCL

# of Institutions

275

Shares Held

45.4M

Call Options Held

58.2K

Put Options Held

10.1K

View Full List

About OMNICELL, Inc

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.56B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

More about OMCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Omnicell, Inc Transaction History